Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis.
<h4>Aims</h4>Several studies reported treatment benefits of tolvaptan in patients with congestive heart failure (CHF). However, the optimal dosage remains unclear. We aimed to compare different dosage of tolvaptan to determine the optimal dosage in terms of the efficacy and safety.<h4...
Saved in:
Main Authors: | Mei-Yi Wu, Tzu-Ting Chen, Ying-Chun Chen, Der-Cherng Tarng, Yun-Chun Wu, Hsien-Ho Lin, Yu-Kang Tu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0184380 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in Thailand
by: Permsuwan U, et al.
Published: (2025-07-01) -
Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes
by: Liliana Italia De Rosa, et al.
Published: (2025-08-01) -
The effects of early exercise on cardiovascular biomarkers in patients with congestive heart failure
by: Yanxiang Sun, et al.
Published: (2025-08-01) -
THE PLACE OF NEBIVOLOL IN RATIONAL THERAPY OF CONGESTIVE HEART FAILURE
by: A. B. Khadzegova
Published: (2014-09-01) -
DOSE-DEPENDENT EFFECTS OF DIPYRIDAMOLE IN PATIENTS WITH CONGESTIVE HEART FAILURE
by: M. P. Savenkov, et al.
Published: (2001-02-01)